Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice

Meaghan Morris, Giselle M. Knudsen, Sumihiro Maeda, Jonathan C. Trinidad, Alexandra Ioanoviciu, Alma L. Burlingame, Lennart Mucke

Research output: Contribution to journalArticle

180 Citations (Scopus)

Abstract

The microtubule-associated protein tau has been implicated in the pathogenesis of Alzheimer's disease (AD) and other neurodegenerative disorders. Reducing tau levels ameliorates AD-related synaptic, network, and behavioral abnormalities in transgenic mice expressing human amyloid precursor protein (hAPP). We used mass spectrometry to characterize the post-translational modification of endogenous tau isolated from wild-type and hAPP mice. We identified seven types of tau modifications at 63 sites in wild-type mice. Wild-type and hAPP mice had similar modifications, supporting the hypothesis that neuronal dysfunction in hAPP mice is enabled by physiological forms of tau. Our findings provide clear evidence for acetylation and ubiquitination of the same lysine residues; some sites were also targeted by lysine methylation. Our findings refute the hypothesis of extensive O-linked N-acetylglucosamine (O-GlcNAc) modification of endogenous tau. The complex post-translational modification of physiological tau suggests that tau is regulated by diverse mechanisms.

Original languageEnglish
Pages (from-to)1183-1189
Number of pages7
JournalNature Neuroscience
Volume18
Issue number8
DOIs
Publication statusPublished - 2015 Aug 30
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Neuroscience(all)
  • Medicine(all)

Cite this

Morris, M., Knudsen, G. M., Maeda, S., Trinidad, J. C., Ioanoviciu, A., Burlingame, A. L., & Mucke, L. (2015). Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice. Nature Neuroscience, 18(8), 1183-1189. https://doi.org/10.1038/nn.4067